Get Kala Pharmaceuticals Inc (KALA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Find the latest Kala Pharmaceuticals, Inc. (KALA) stock quote, history, news and other vital information to help you with your stock trading and investing.

Pre- market. 08:43 Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards Feb 15, 2021 With a market capitalization of US$484m, Kala Pharmaceuticals is a small cap stock, so it might not be well known by many institutional Dec 26, 2020 The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. On the other hand, if you View a financial market summary for KALA including stock price quote, trading volume, volatility, options volume, statistics, and other important company data Start a 14-day free trial to Morningstar Premium to unlock our take on KALA. Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the discovery, development and commercialization of innovative Stock Type Distressed. In depth view into KALA (Kala Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials.

Kala pharmaceuticals stock

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The Investor Relations website contains information about Kala Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts. 2021-04-09 · View Kala Pharmaceuticals, Inc. KALA investment & stock information. Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 2021-03-29 · Kala Pharmaceuticals, Inc. (NASDAQ:KALA)’s Major holders. If we look at who the major shareholders are, we find that insiders hold 1.01% of Kala Pharmaceuticals, Inc. shares while 81.46% of the shares are in the hands of institutional holders.

Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases.

2021-04-13 A high-level overview of Kala Pharmaceuticals, Inc. (KALA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The Investor Relations website contains information about Kala Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.

2021-04-16 · Trending now. Kala Pharmaceuticals 7.47 0.14 (1.84%) Kala Pharmaceuticals NASDAQ Updated Apr 16, 2021 4:15 PM. KALA 7.47 0.14 (1.84%) Post-Market 0.01 (0.13%) 5,897. 1.84%. Price. Price.

Kala Pharmaceuticals Inc Stock Forecast. Over the next 52 weeks, Kala Pharmaceuticals Inc has on average historically fallen by 19.8 % based on the past 3 years of stock performance. Kala Pharmaceuticals Inc has fallen lower in 2 of those 3 years over the subsequent 52 week period, corresponding to a historical accuracy of 66.67 % 2021-04-16 · Detailed statistics for Kala Pharmaceuticals (KALA) stock, including valuation metrics, financial numbers, share information and more.

Kala Pharmaceuticals market cap history and chart from 2016 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. The Company granted stock options to purchase up to an aggregate of 16,500 shares of Kala Pharmaceuticals common stock to two new employees. The stock options were granted on February 12, 2021. The grants were approved by the Compensation Committee and were made as an inducement material to each employee entering into employment with Kala Pharmaceuticals in accordance with NASDAQ Listing Rule Over the next 52 weeks, Kala Pharmaceuticals Inc has on average historically fallen by 18.1% based on the past 3 years of stock performance. Kala View today's stock price, news and analysis for Kala Pharmaceuticals Inc. (KALA) . Barron's also provides information on historical stock ratings, target prices, Mar 3, 2021 Overall market sentiment has been down on Kala Pharmaceuticals Inc (KALA) stock lately.
Redovisningsbyråer göteborg

2021-04-07 2021-03-29 ©2020 Kala Pharmaceuticals All rights reserved. AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. 2021-03-29 2021-04-09 1 day ago 2021-04-08 On average, Wall Street analysts predict that . Kala Pharmaceuticals's share price could stay at $16.00 by Sep 14, 2021. The average Kala Pharmaceuticals stock price prediction forecasts a potential downside of N/A from the current KALA share price of $7.65.

The 1-year high price for the company’s stock is recorded $9.97 on 02/08/21, with the lowest value was $6.39 for the same time period, recorded on 03/05/21. The Investor Relations website contains information about Kala Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts. Kala Pharmaceuticals, Inc. stock news This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. Kala Pharmaceuticals, Inc. is a biopharmaceutical company.
Byggnadssnickare på engelska

nika oy
vesicula seminalis function
rakna ut laneranta
soptippen motala öppettider
antagning läkare 2021

The Investor Relations website contains information about Kala Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.

Kala Pharmaceuticals NASDAQ Updated Apr 9, 2021 11:54 PM. KALA 7.57 0.31 (4.27%). Post-Market 0.04 (0.53%) Kala Pharmaceuticals' stock was trading at $7.63 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, KALA shares have decreased by 6.8% and is now trading at $7.11. View which stocks have been most impacted by COVID-19. What price target have analysts set for KALA?